DOI: https://doi.org/10.24061/115880

Моніторинг частоти метаболічного синдрому та основних його критеріів у дітей

N. M. Hromnatska

Анотація


На підставі клінічно-параклінічного обстеження 152 дітей і підлітків загальної популяції встановлено, що частота метаболічного синдрому в  дітей становить 5,9 %. Рівень виявлення метаболічного синдрому в дітей української популяції не відрізняється від загальносвітових. Відмічено, що для відображення реальної епідеміологічної ситуації в Україні з поширеності метаболічних захворювань із метою їх профілактики та своєчасної корекції, необхідно впровадити моніторинг метаболічного синдрому.


Ключові слова


метаболічний синдром; критерії; частота діагностики; діти

Повний текст:

PDF

Посилання


Butrova SA, Dzagoeva FKh. Vistseral'noe ozhirenie - klyuchevoe zveno metabolicheskogo sindroma [Visceral obesity is a key link in the metabolic syndrome]. Ozhirenie i metabolism. 2004;1:10-6. (in Russian).

Bilets'kyi SV, Kazantseva TV, Zorii IA. Kliniko-biokhimichni markery metabolichnoho syndrome pry arterial'nii hipertenzii u doroslykh i ditei [Clinical and biochemical markers of metabolic syndrome with hypertension in adults and children]. Buk. med. visnyk. 2008;12(1):75-81. (in Ukrainian).

Kozhukhar OV, Khaitovych MV, Terlets'kyi RV. Markery metabolichnoho syndromu u ditei i pidlitkiv (ohliad literatury ta rezul'taty vlasnykh doslidzhen') [Markers of metabolic syndrome in children and adolescents (review of literature and results of own research)]. Pediatriia, akusherstvo ta hinekol. 2006;2:37-41. (in Ukrainian).

Krasnoperova OI, Smirnova EN, Merzlova NB. Faktory, privodyashchie k razvitiyu ozhireniya u detey i sposobstvuyushchie ego transformatsii v MS [Factors leading to the development of obesity in children and facilitating its transformation into the MS]. Fundamental'nye issledovaniya. 2012;4:306-10. (in Russian).

Leont'eva IV, Moreno IG, Neudakhin EV, Remizov OV. IX Rossiyskiy natsional'nyy kongress [“Chelovek i lekarstvo”] [IX Russian National Congress ["Man and medicine"]]. Moskow; 2002. 261 p. (in Russian).

Maidannyk VH, Moskalenka VF, editors. Pervynna arterial'na hipertenziia u ditei i pidlitkiv [Primary arterial hypertension in children and adolescents]. TOV “Avrpost-Prym”; Kyiv; 2007. 389 p. (in Ukrainian).

Malyavskaya SI. Pediatricheskiy metabolicheskiy sindrom: sostoyanie vysokogo riska [Pediatric metabolic syndrome: a high-risk]. Pediatriya. 2010;89(4):119-22. (in Russian).

Manovitskaya AV. Klinicheskie effekty primeneniya taurina u bol'nykh s metabolicheskim sindromom [Clinical effects of taurine in patients with metabolic syndrome]. Vopr. pitannya. 2011;80(3):57-61. (in Russian).

Zav'yalova LG, Denisova DV, Simonova GI. Metabolicheskiy sindrom i ozhirenie u podrostkov [Metabolic syndrome and obesity in adolescents]. Kardiovaskulyarnaya terapiya i profilaktika. 2006;5-6:147-48. (in Russian).

Dedov II, Mel'nichenko GA, Butrova SA. Ozhirenie v podrostkovom vozraste. Rezul'taty rossiyskogo epidemiologicheskogo issledovaniya [Obesity in adolescence. Results of the Russian epidemiological study]. Terapevt. arkh. 2007;79(2):28-32. (in Russian).

Pyrtsu L, Rud' M, Paliy I. Ozhirenie u detey kak faktor riska razvitiya arterial'noy gipertenzii v detskom vozraste [Obesity in children as a risk factor for the development of hypertension in child hood]. Perinatol. i pediatriya. 2012;1:78-80. (in Russian).

Ryabova TI, Popova TV. Vysokie tekhnologii v endokrinologii [High technology in endocrinology]. Materials of the V All-Russian Congress of Endocrinologists. Moskow; 2006. 203 p. (in Russian).

Fomina IG, Gaydamakina NE, D'yakova TA. Sutochnyy ritm arterial'nogo davleniya i funktsiya pochek u muzhchin s essentsial'noy arterial'noy gipertenziey [Daily rhythm of blood pressure and function kidney in men with essential hypertension]. Kardiovaskulyarnaya terapiya i profilaktika. 2006;4:28-32. (in Russian).

Shutova EV. Narusheniya metabolizma lipidov u detey s zabolevaniyami biliarnoy sistemy (Obzor literatury) [Disorders of lipid metabolism in children with diseases of the biliary system (Review of the literature)]. Perinatol. i pediatriya. 2010;2:61-2. (in Russian).

Shcherbakova MY, Poryadina GI, Kovaleva GI. Problema ozhireniya i metabolicheskogo sindroma u detey [The problem of obesity and metabolic syndrome in children]. Ross. vestn. perinatol. i pediatrii. 2010;5:52-4. (in Russian).

Emel'yanchik EYu, Taranushenko TE, Kirillova TE. Epidemiologiya arterial'noy gipertenzii v detskoy populyatsii g. Krasnoyarska [Epidemiology of arterial hypertension in the children's population of Krasnoyarsk]. Ross. pediatr. zh. 2002;6:9-13. (in Russian).

Rudenko VG, Yakimenko EA, Borshch VI. Effektivnost' lecheniya arterial'noy gipertenzii na ambulatorno-poliklinicheskom etape [The effectiveness of treatment of hypertension in out-patient-polyclinic stage]. Materials of the XV Congress of Physicians ofUkraine. Kyiv: SPD Koliada O.P.; 2004. 83 p. (in Russian).

Atabek ME, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract. 2006;72(3):315-21.

Grundy S, Brewer H, Cieeman J. Definition of metabolic syndrome. Report of National Heart, Lung, and Blood Institute. Am. Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433-38.

Ginsberg YN, MacCollum P. The obesity, metabolic syndrome and type 2 diabetes mellitus pandemic: Part 1. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with metabolic syndrome and type 2 diabetes mellitus. J Cardiometab. Syn. 2009;4(2):113-19.

Gregg EW. Are children the future of type 2 diabetes prevention. N. Engl. J. Med. 2010;362:548-50.

Zimmet P, Alberti KG, Kaufman FT. IDF Consensus. The metabolic syndrome in children and adolescents. –an IDF consensus report. Pediat. Diabetes. 2007;8(5):299-306.

Kohli P, Greenland P. Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA. 2006;295:819-21.

Carroll MD, Curtin LR, Lamb MM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303:242-49.

Singh GK. Metabolic syndrome in children and adolescents. Curr. Treat. Options Cardiovasc. Med. 2006;5:403-13.

Simmons RK, Alberti KGM, Gale EAM. The metabolic syndrome: useful concept or clinical tool. Report of a WHO Expert consultation. Diabetologia. 2010;53:600-605.

The Third Report of the National Cholesterol Education Program (NCEP) Erpert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III) NIH Publication. 2001;5:67.

Weiss R, Carpio S. The metabolic consequenses of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005;19:405-19.

Wilding JPH. Treatment strategies for obesity. Obesity Reviews. 2007;8:134-44.

Zimmet P, Shaw J, Alberti G. Preventing type 2 diabetes and the metabolic syndrome in the real world: a realiastic view. Diabet Med. 2003;20(9):693-702.


Пристатейна бібліографія ГОСТ






Copyright (c) 2017 N. M. Hromnatska

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2018